DE69333375D1 - Verbesserungen in oder bezogen auf modifikationen der immunantwort - Google Patents

Verbesserungen in oder bezogen auf modifikationen der immunantwort

Info

Publication number: DE69333375D1
Authority: DE; Germany
Prior art keywords: modifications; immune response; immune; response
Prior art date: 1992-10-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE69333375T

Other languages

English (en)

Other versions

DE69333375T2 (de

Inventor

Robert Edward Hawkins

Stephen James Russell

Freda Katherine Stevenson

Gregory Paul Winter

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Cancer Research Technology Ltd

Original Assignee

Cancer Research Technology Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-10-02

Filing date

1993-10-04

Publication date

2004-02-05

1993-10-04 Application filed by Cancer Research Technology Ltd filed Critical Cancer Research Technology Ltd

2004-02-05 Application granted granted Critical

2004-02-05 Publication of DE69333375D1 publication Critical patent/DE69333375D1/de

2004-12-09 Publication of DE69333375T2 publication Critical patent/DE69333375T2/de

2013-10-05 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

DE69333375T 1992-10-02 1993-10-04 Verbesserungen in oder bezogen auf modifikationen der immunantwort Expired - Fee Related DE69333375T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB9220808		1992-10-02
GB929220808A GB9220808D0 (en)	1992-10-02	1992-10-02	Antibody genes
PCT/GB1993/002054 WO1994008008A1 (en)	1992-10-02	1993-10-04	Improvements in or relating to immune response modification

Publications (2)

Publication Number	Publication Date
DE69333375D1 true DE69333375D1 (de)	2004-02-05
DE69333375T2 DE69333375T2 (de)	2004-12-09

Family

ID=10722895

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69333375T Expired - Fee Related DE69333375T2 (de)	1992-10-02	1993-10-04	Verbesserungen in oder bezogen auf modifikationen der immunantwort

Country Status (7)

Country	Link
EP (1)	EP0663008B1 (de)
JP (1)	JP4011105B2 (de)
AU (1)	AU685399B2 (de)
CA (1)	CA2145064C (de)
DE (1)	DE69333375T2 (de)
GB (1)	GB9220808D0 (de)
WO (1)	WO1994008008A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4237113B4 (de) *	1992-11-03	2006-10-12	"Iba Gmbh"	Peptide und deren Fusionsproteine, Expressionsvektor und Verfahren zur Herstellung eines Fusionsproteins
CA2161095A1 (en) *	1993-04-20	1994-10-27	Solis Therapeutics, Inc.	Methods and materials for treatment of individuals infected with intracellular infectious agents
WO1996036714A1 (fr) *	1995-05-18	1996-11-21	Takara Shuzo Co., Ltd.	Molecule d'acide nucleique pour le traitement de tumeurs malignes de lymphocytes b, procede pour la produire et son utilisation.
US7084256B2 (en)	1999-09-24	2006-08-01	Large Scale Biology Corporation	Self antigen vaccines for treating B cell lymphomas and other cancers
TWI333977B (en)	2003-09-18	2010-12-01	Symphogen As	Method for linking sequences of interest
CA2677771A1 (en)	2007-03-01	2008-09-04	Symphogen A/S	Method for cloning cognate antibodies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9015198D0 (en) *	1990-07-10	1990-08-29	Brien Caroline J O	Binding substance

1992
- 1992-10-02 GB GB929220808A patent/GB9220808D0/en active Pending
1993
- 1993-10-04 CA CA002145064A patent/CA2145064C/en not_active Expired - Fee Related
- 1993-10-04 WO PCT/GB1993/002054 patent/WO1994008008A1/en active IP Right Grant
- 1993-10-04 DE DE69333375T patent/DE69333375T2/de not_active Expired - Fee Related
- 1993-10-04 JP JP50885994A patent/JP4011105B2/ja not_active Expired - Fee Related
- 1993-10-04 AU AU48324/93A patent/AU685399B2/en not_active Ceased
- 1993-10-04 EP EP93921048A patent/EP0663008B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2145064A1 (en)	1994-04-14
AU4832493A (en)	1994-04-26
JPH08501699A (ja)	1996-02-27
JP4011105B2 (ja)	2007-11-21
DE69333375T2 (de)	2004-12-09
WO1994008008A1 (en)	1994-04-14
EP0663008B1 (de)	2004-01-02
EP0663008A1 (de)	1995-07-19
GB9220808D0 (en)	1992-11-18
CA2145064C (en)	2006-12-19
AU685399B2 (en)	1998-01-22

Publication	Publication Date	Title
KR890020593U (ko)	1989-11-01	가구 등의 보호각
ZA772448B (en)	1978-07-26	Improvements in or relating to the moulding of panels and the like
DE69311706D1 (de)	1997-07-24	Verbesserung in oder in bezug auf reinigungsmittel
DE69215889D1 (de)	1997-01-23	Antireflexbeschichtungen
FI942166L (fi)	1994-07-08	Menetelmiä restenoosin ehkäisemiseksi
DE69431789D1 (de)	2003-01-09	Verbesserungen in oder in Bezug auf EEPROMs
FI91840C (fi)	1994-08-25	Ennalleen saatettava tuote
DK263588A (da)	1988-11-17	Proterinstof med tnf-virkning
DE69212603D1 (de)	1996-09-05	Verbesserungen von oder mit bezug auf kreiselgeräte
DE69413794D1 (de)	1998-11-12	Verbesserungen an oder bezugnehmend auf Klammern die Verwendung derselben
DE69307016D1 (de)	1997-02-13	Einrichtung zur Veränderung der Steuerzeiten
PT90054A (pt)	1989-11-10	Artigo protetico
DE69333375D1 (de)	2004-02-05	Verbesserungen in oder bezogen auf modifikationen der immunantwort
DE59305333D1 (de)	1997-03-13	Passive Schaltungsanordnung zur Verbesserung des Leistungsfaktor
FI910897A7 (fi)	1991-08-29	(S)-norfluoksetiiniin liittyviä parannuksia
GB9121627D0 (en)	1991-11-27	Improvements in or relating to the covering of surfaces
GB2281961B (en)	1997-01-08	Improvements in or relating to the movement of members
KR890701257A (ko)	1989-12-19	적층 테이프 및 그 사용방법
DE69219764D1 (de)	1997-06-19	Schutzlackstruktur
FI840474A7 (fi)	1984-08-08	Parannuksia nitsatidiinin synteesissä sekä synteesiin liittyviä parannuksia.
DE69323582D1 (de)	1999-04-01	Jungaal ähnliches Artifizielles Nahrungsmittel
KR880015109U (ko)	1988-09-14	연약한 지반용 전주 근가
GB9005411D0 (en)	1990-05-09	Improvements in or relating to the survey of areas
KR910018297U (ko)	1991-11-28	에스컬레이터의 내지진형 턱받침부 구조
KR930024237U (ko)	1993-11-27	대금의 구조

Legal Events

Date	Code	Title	Description
2005-01-27	8364	No opposition during term of opposition
2010-08-19	8339	Ceased/non-payment of the annual fee